Literature DB >> 16267004

A network of genetic events sufficient to convert normal human cells to a tumorigenic state.

S DiSean Kendall1, Corinne M Linardic, Stacey J Adam, Christopher M Counter.   

Abstract

Although great progress has been made at identifying and characterizing individual genes involved in cancer, less is known about how the combination of such genes collaborate to form tumors in humans. To this end, we sought to genetically recreate tumorigenesis in normal human cells using genes altered in human cancer. We now show that expression of mammalian proteins that inactivate the tumor suppressors Rb and p53 in conjunction with the oncoproteins Ras and Myc and the telomerase subunit hTERT is sufficient to drive a number of normal human somatic cells to a tumorigenic fate. This provides a blueprint of the events that lead to human cancer, allowing different cancers to be genetically modeled from normal human cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267004     DOI: 10.1158/0008-5472.CAN-05-1543

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.

Authors:  Lisa E S Crose; Katherine T Etheridge; Candy Chen; Brian Belyea; Lindsay J Talbot; Rex C Bentley; Corinne M Linardic
Journal:  Clin Cancer Res       Date:  2012-05-30       Impact factor: 12.531

2.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.

Authors:  Christopher G Hubert; Robert K Bradley; Yu Ding; Chad M Toledo; Jacob Herman; Kyobi Skutt-Kakaria; Emily J Girard; Jerry Davison; Jason Berndt; Philip Corrin; Justin Hardcastle; Ryan Basom; Jeffery J Delrow; Thomas Webb; Steven M Pollard; Jeongwu Lee; James M Olson; Patrick J Paddison
Journal:  Genes Dev       Date:  2013-05-01       Impact factor: 11.361

3.  Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Sandeep Sreevalsan; Satya Pathi; Kyounghyun Kim; Candy Chen; Lisa Crose; Corinne Linardic; Stephen Safe
Journal:  Int J Cancer       Date:  2012-08-03       Impact factor: 7.396

4.  Enhancing the efficiency of direct reprogramming of human primary fibroblasts into dopaminergic neuron-like cells through p53 suppression.

Authors:  XinJian Liu; Qian Huang; Fang Li; Chuan-Yuan Li
Journal:  Sci China Life Sci       Date:  2014-08-16       Impact factor: 6.038

Review 5.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

6.  BuGZ is required for Bub3 stability, Bub1 kinetochore function, and chromosome alignment.

Authors:  Chad M Toledo; Jacob A Herman; Jonathan B Olsen; Yu Ding; Philip Corrin; Emily J Girard; James M Olson; Andrew Emili; Jennifer G DeLuca; Patrick J Paddison
Journal:  Dev Cell       Date:  2014-01-23       Impact factor: 12.270

7.  Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth.

Authors:  Y Liu; S Yan; A Wondimu; D Bob; M Weiss; K Sliwinski; J Villar; V Notario; M Sutherland; A M Colberg-Poley; S Ladisch
Journal:  Oncogene       Date:  2010-03-22       Impact factor: 9.867

8.  Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations.

Authors:  Mitsuo Sato; Jill E Larsen; Woochang Lee; Han Sun; David S Shames; Maithili P Dalvi; Ruben D Ramirez; Hao Tang; John Michael DiMaio; Boning Gao; Yang Xie; Ignacio I Wistuba; Adi F Gazdar; Jerry W Shay; John D Minna
Journal:  Mol Cancer Res       Date:  2013-02-28       Impact factor: 5.852

9.  Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcoma.

Authors:  Sarasija Naini; Katherine T Etheridge; Stacey J Adam; Stephen J Qualman; Rex C Bentley; Christopher M Counter; Corinne M Linardic
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

10.  Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic Factors.

Authors:  Fang Li; Xinjian Liu; John H Sampson; Darell D Bigner; Chuan-Yuan Li
Journal:  Cancer Res       Date:  2016-06-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.